Atlas Trials

A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase Inhibitor

Clinical trial NCT01760343 · COMPLETED

Trial details

NCT number
NCT01760343
Sponsor
CSL Behring
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hereditary Angioedema Types I and II
Start date
2013-01-01
Primary completion
2013-03-01
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.